Skip to main content
Figure 3 | Journal of Translational Medicine

Figure 3

From: Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab

Figure 3

Forest plots from multivariate Cox regression models in the HER2-positive patients. A: Time to progression (N=117). Among the TOP2A deleted subgroup, anthracycline-treated patients were associated with increased risk for progression. B: Survival (N=117). Among the TOP2A amplified subgroup, anthracycline-treated patients were associated with decreased risk for death.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us